Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study

The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD). The baseline data of 5511 subject...

Full description

Saved in:
Bibliographic Details
Published inJournal of diabetes and its complications Vol. 30; no. 2; pp. 269 - 274
Main Authors Motamed, Nima, Miresmail, Seyed Javad Haji, Rabiee, Behnam, Keyvani, Hossein, Farahani, Behzad, Maadi, Mansooreh, Zamani, Farhad
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2016
Elsevier Limited
Subjects
Online AccessGet full text
ISSN1056-8727
1873-460X
1873-460X
DOI10.1016/j.jdiacomp.2015.11.019

Cover

Abstract The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD). The baseline data of 5511 subjects aged ≥18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively. Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions.
AbstractList The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD). The baseline data of 5511 subjects aged ≥18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively. Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions.
Abstract Aims The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD). Methods The baseline data of 5511 subjects aged ≥ 18 years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Results The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity = 64.4%, specificity = 66.8%] and 1.79 [sensitivity = 66.2%, specificity = 62.2%] in men and were 2.5 [sensitivity = 57.6%, specificity = 67.9%] and 1.95 [sensitivity = 65.1%, specificity = 54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity = 63.7%, specificity = 67.8%] and 0.347 [sensitivity = 62.9%, specificity = 65.0%] in men and were 0.331 [sensitivity = 55.7%, specificity = 70.7%] and 0.333 [sensitivity = 53.2%, specificity = 67.7%] in women respectively. Conclusion Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions.
The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD).AIMSThe present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD).The baseline data of 5511 subjects aged ≥18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD.METHODSThe baseline data of 5511 subjects aged ≥18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD.The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively.RESULTSThe optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively.Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions.CONCLUSIONNot only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions.
Aims The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD). Methods The baseline data of 5511 subjects aged >=18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Results The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively. Conclusion Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions.
Aims The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD). Methods The baseline data of 5511 subjects aged greater than or equal to 18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Results The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively. Conclusion Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions.
Author Maadi, Mansooreh
Miresmail, Seyed Javad Haji
Farahani, Behzad
Motamed, Nima
Zamani, Farhad
Rabiee, Behnam
Keyvani, Hossein
Author_xml – sequence: 1
  givenname: Nima
  surname: Motamed
  fullname: Motamed, Nima
  organization: Department of Social Medicine, Zanjan University of Medical Sciences, Gavazang Road, Zanjan, Iran
– sequence: 2
  givenname: Seyed Javad Haji
  surname: Miresmail
  fullname: Miresmail, Seyed Javad Haji
  organization: Department of Cardiology, Hazrat Rasoul Hospital, Iran University of Medical Sciences, Niayesh St. Satarkhan Ave., 1445613131, Tehran, Iran
– sequence: 3
  givenname: Behnam
  surname: Rabiee
  fullname: Rabiee, Behnam
  organization: Gastroenterology and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Beh Afarin St., Karim Khan Zand Ave., 15900, Tehran, Iran
– sequence: 4
  givenname: Hossein
  surname: Keyvani
  fullname: Keyvani, Hossein
  organization: Department of Virology, Tehran University of Medical Sciences, Poursina St, 16 Azar Ave, Keshavarz BLVD, Tehran, Iran
– sequence: 5
  givenname: Behzad
  surname: Farahani
  fullname: Farahani, Behzad
  organization: Gastroenterology and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Beh Afarin St., Karim Khan Zand Ave., 15900, Tehran, Iran
– sequence: 6
  givenname: Mansooreh
  surname: Maadi
  fullname: Maadi, Mansooreh
  organization: Gastroenterology and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Beh Afarin St., Karim Khan Zand Ave., 15900, Tehran, Iran
– sequence: 7
  givenname: Farhad
  surname: Zamani
  fullname: Zamani, Farhad
  email: Zamani.Farhad@gmail.com
  organization: Gastroenterology and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Beh Afarin St., Karim Khan Zand Ave., 15900, Tehran, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26718936$$D View this record in MEDLINE/PubMed
BookMark eNqNUl2LEzEUHWTF_dC_sAR88WVqkk4-RkQsRd3iSvFjwbeQyWTc1EwyJpmF_o79w5u2W4Q-WJ8SknPOvffcc16cOO90UVwiOEEQ0deryao1Uvl-mGCIyAShCUT1k-IMcTYtKwp_nuQ7JLTkDLPT4jzGFYSQEoKeFaeYMsTrKT0r7pdDMr20QI3Jdx0YvHEpgs4HcLX8MisX34B0Lfh6s5h_XgDjQLrVIFf-5Xw0EfgO9DrJxlujQFy7Nvhebxm531Ja5W-3X51MaQ2sudMhs6OWUb8Bs1xtGK1MxjvQ5KcWxDS26-fF007aqF88nhfFzccPP-ZX5fXy02I-uy4VhSSVqOkw4ZA3VZ5ESdnKCjc1o1NWM84h5o3qKk4qifi0hrhhHdOsIUghVMMG0-lF8WqnOwT_Z9Qxid5Epa2VTvsxCsQxqzGsSHUcyiiDjLMt9OUBdOXH4PIgGxQlNa5YnVGXj6ix6XUrhpC3ENZiv5kMeLsDqOBjDLoTyqStVSlIYwWCYhMEsRL7IIhNEARCIgch0-kBfV_hKPH9jqiz83dGBxGV0U7p1gStkmi9OS7x7kBCWeOMkva3Xuv41w4RsYDi-yamm5QiArPZDP9b4H86eAArmfnj
CitedBy_id crossref_primary_10_25048_tudod_1461623
crossref_primary_10_4093_jkd_2021_22_3_207
crossref_primary_10_1038_s41598_022_27269_6
crossref_primary_10_1016_j_carbpol_2017_08_071
crossref_primary_10_1038_s41598_024_81551_3
crossref_primary_10_1002_edm2_70006
crossref_primary_10_1016_j_numecd_2023_08_020
crossref_primary_10_3390_ijms23020786
crossref_primary_10_1210_clinem_dgaa265
crossref_primary_10_3389_fpubh_2022_1006332
crossref_primary_10_1002_ptr_6487
crossref_primary_10_3389_fendo_2024_1329380
crossref_primary_10_1080_00015385_2017_1410335
crossref_primary_10_1089_jmf_2022_K_0019
crossref_primary_10_1371_journal_pone_0165689
crossref_primary_10_3390_ijerph182010986
crossref_primary_10_1136_bmjopen_2018_025674
crossref_primary_10_7570_jomes21093
crossref_primary_10_1016_j_tjog_2020_09_014
crossref_primary_10_1007_s00125_017_4340_1
crossref_primary_10_12677_ACM_2023_13102233
crossref_primary_10_1371_journal_pone_0317607
crossref_primary_10_1039_C8FO01323C
crossref_primary_10_1016_j_nut_2019_01_008
crossref_primary_10_1161_STROKEAHA_116_014097
crossref_primary_10_1016_j_atherosclerosis_2024_117508
crossref_primary_10_7570_jomes21065
crossref_primary_10_4103_jss_jss_346_23
crossref_primary_10_12688_f1000research_106723_2
crossref_primary_10_1016_j_jacl_2016_02_013
crossref_primary_10_12688_f1000research_106723_1
crossref_primary_10_1002_oby_22276
crossref_primary_10_1055_a_1831_0265
crossref_primary_10_3389_fnut_2023_1155436
crossref_primary_10_7759_cureus_50524
crossref_primary_10_1111_jch_14600
crossref_primary_10_1186_s12944_017_0618_z
crossref_primary_10_36106_2801124
crossref_primary_10_3390_nu16091381
crossref_primary_10_1186_s13104_018_3212_1
crossref_primary_10_1016_j_ypmed_2017_11_007
crossref_primary_10_1016_j_tmsr_2018_04_001
crossref_primary_10_3803_EnM_2021_1110
crossref_primary_10_4103_ijnmr_ijnmr_451_20
crossref_primary_10_1136_bmjopen_2018_026337
crossref_primary_10_15171_mejdd_2017_56
crossref_primary_10_1007_s40200_023_01347_6
crossref_primary_10_1177_11795514231168279
crossref_primary_10_1186_s12944_020_01410_8
crossref_primary_10_1002_oby_23438
crossref_primary_10_1038_s41598_020_67238_5
crossref_primary_10_5812_hepatmon_102972
Cites_doi 10.1002/hep.25539
10.3390/nu5051544
10.1126/science.1204265
10.1186/1472-6823-13-47
10.4274/Jcrpe.1127
10.1038/nrm1837
10.1053/j.gastro.2012.02.003
10.1053/gast.2001.23256
10.1001/jama.287.3.356
10.1590/S0004-28032010000200009
10.2337/dc08-1800
10.1210/jcem.87.1.8292
10.1038/sj.jhh.1002201
10.1016/S0140-6736(05)66378-7
10.1016/j.cmet.2012.03.005
10.1038/nrm2327
10.2337/diabetes.54.7.1914
10.1111/j.1365-2036.2010.04556.x
10.1016/S0140-6736(95)92143-5
10.1056/NEJM199312303292703
10.1007/BF00280883
10.4239/wjd.v1.i2.36
10.1001/jama.283.2.221
10.1002/hep.23280
10.2337/diab.37.12.1595
ContentType Journal Article
Copyright 2016 Elsevier Inc.
Elsevier Inc.
Copyright © 2016 Elsevier Inc. All rights reserved.
Copyright Elsevier Limited Mar 2016
Copyright_xml – notice: 2016 Elsevier Inc.
– notice: Elsevier Inc.
– notice: Copyright © 2016 Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Limited Mar 2016
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8AO
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AN0
ASE
AZQEC
BENPR
CCPQU
DWQXO
FPQ
FYUFA
GHDGH
GNUQQ
GUQSH
K6X
K9-
K9.
KB0
M0R
M0S
M1P
M2O
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
7X8
7T5
H94
DOI 10.1016/j.jdiacomp.2015.11.019
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & allied health premium.
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest British Nursing Database
British Nursing Index
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
British Nursing Index (BNI) (1985 to Present)
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
British Nursing Index
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
ProQuest Health & Medical Collection
Medical Database
Research Library
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
British Nursing Index
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList MEDLINE

MEDLINE - Academic
Research Library Prep
AIDS and Cancer Research Abstracts


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1873-460X
EndPage 274
ExternalDocumentID 3957640391
26718936
10_1016_j_jdiacomp_2015_11_019
S1056872715004572
1_s2_0_S1056872715004572
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29K
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8FI
8FJ
8G5
8P~
9JM
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ABUWG
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFKRA
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AN0
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BENPR
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BNQBC
BPHCQ
BVXVI
CCPQU
CS3
D-I
DU5
DWQXO
EBS
EFJIC
EFKBS
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-2
G-Q
GBLVA
GNUQQ
GUQSH
HDZ
HMCUK
HMK
HMO
HVGLF
HZ~
IHE
J1W
K-O
K9-
KOM
L7B
LZ1
M0R
M1P
M29
M2O
M41
MO0
N9A
NAPCQ
O-L
O9-
OAUVE
OB0
ON-
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
SV3
T5K
UKHRP
WOW
WUQ
Z5R
~G-
3V.
AACTN
AFCTW
AFKWA
AJOXV
ALIPV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AJBFU
DOVZS
EFLBG
LCYCR
AAYXX
ACLOT
CITATION
~HD
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AGRNS
ASE
FPQ
K6X
K9.
MBDVC
PKEHL
PQEST
PQUKI
Q9U
7X8
7T5
H94
ID FETCH-LOGICAL-c605t-1bf25808b4936caada42b976379788028bcf4854a183902b7f7e7b51c1190b263
IEDL.DBID 7X7
ISSN 1056-8727
1873-460X
IngestDate Sun Sep 28 10:17:50 EDT 2025
Sat Sep 27 21:28:45 EDT 2025
Sat Jul 26 02:26:50 EDT 2025
Wed Feb 19 02:00:29 EST 2025
Wed Oct 01 01:28:40 EDT 2025
Thu Apr 24 23:06:27 EDT 2025
Fri Feb 23 02:24:52 EST 2024
Sun Feb 23 10:19:08 EST 2025
Tue Aug 26 16:31:53 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Homeostatic model assessment index
Metabolic syndrome
Non-alcoholic fatty liver disease
Diagnostic index
Quantitative insulin sensitivity check index
Language English
License Copyright © 2016 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c605t-1bf25808b4936caada42b976379788028bcf4854a183902b7f7e7b51c1190b263
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 26718936
PQID 1766592479
PQPubID 1226340
PageCount 6
ParticipantIDs proquest_miscellaneous_1827920454
proquest_miscellaneous_1767078754
proquest_journals_1766592479
pubmed_primary_26718936
crossref_citationtrail_10_1016_j_jdiacomp_2015_11_019
crossref_primary_10_1016_j_jdiacomp_2015_11_019
elsevier_sciencedirect_doi_10_1016_j_jdiacomp_2015_11_019
elsevier_clinicalkeyesjournals_1_s2_0_S1056872715004572
elsevier_clinicalkey_doi_10_1016_j_jdiacomp_2015_11_019
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-03-01
PublicationDateYYYYMMDD 2016-03-01
PublicationDate_xml – month: 03
  year: 2016
  text: 2016-03-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Philadelphia
PublicationTitle Journal of diabetes and its complications
PublicationTitleAlternate J Diabetes Complications
PublicationYear 2016
Publisher Elsevier Inc
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
References Zamani, Sohrabi, Alipour, Motamed, Saeedian, Pirzad, Khonsari (bb0085) 2014; 17
Ford, Giles, Dietz (bb0045) 2002; 287
Chen, Sullivan, Quon (bb0140) 2005; 54
Cusi (bb0125) 2012; 142
Gayoso-Diz, Otero-Gonzalez, Rodriguez-Alvarez, Gude, Garcia, De Francisco, Quintela (bb0105) 2013; 13
Singh, Garg, Tandon, Marwaha (bb0110) 2013; 5
Jornayvaz, Shulman (bb0120) 2012; 15
Salgado, Carvalho, Oliveira, Santos, Vieira, Parise (bb0115) 2010; 47
Dowman, Tomlinson, Newsome (bb0100) 2011; 33
Muoio, Newgard (bb0010) 2008; 9
Singh, Saxena (bb0075) 2010; 1
Fabbrini, Sullivan, Klein (bb0060) 2010; 51
Gaggini, Morelli, Buzzigoli, DeFronzo, Bugianesi, Gastaldelli (bb0135) 2013; 5
Eckel, Grundy, Zimmet (bb0040) 2005; 365
Motamed, Razmjou, Hemmasi, Maadi, Zamani (bb0090) 2015
Lomonaco, Ortiz-Lopez, Orsak, Webb, Hardies, Darland, Cusi (bb0130) 2012; 55
Duncan, Singh, Wise, Carter, Alaghband-Zadeh (bb0070) 1995; 346
Meigs, Mittleman, Nathan, Tofler, Singer, Murphy-Sheehy, Wilson (bb0015) 2000; 283
Cohen, Horton, Hobbs (bb0055) 2011; 332
Taniguchi, Emanuelli, Kahn (bb0005) 2006; 7
Lillioja, Mott, Spraul, Ferraro, Foley, Ravussin, Bogardus (bb0020) 1993; 329
Sarafidis, Lasaridis, Nilsson, Pikilidou, Stafilas, Kanaki, Bakris (bb0145) 2007; 21
Sanyal, Campbell-Sargent, Mirshahi, Rizzo, Contos, Sterling, Clore (bb0025) 2001; 120
Hrebicek, Janout, Malincikova, Horakova, Cizek (bb0080) 2002; 87
Argiles, Lopez-Soriano (bb0030) 2001; 18
Delavari, Forouzanfar, Alikhani, Sharifian, Kelishadi (bb0095) 2009; 32
Reaven (bb0035) 1988; 37
Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (bb0065) 1985; 28
Hajian-Tilaki (bb0050) 2015; 6
Reaven (10.1016/j.jdiacomp.2015.11.019_bb0035) 1988; 37
Matthews (10.1016/j.jdiacomp.2015.11.019_bb0065) 1985; 28
Lillioja (10.1016/j.jdiacomp.2015.11.019_bb0020) 1993; 329
Argiles (10.1016/j.jdiacomp.2015.11.019_bb0030) 2001; 18
Gaggini (10.1016/j.jdiacomp.2015.11.019_bb0135) 2013; 5
Cusi (10.1016/j.jdiacomp.2015.11.019_bb0125) 2012; 142
Dowman (10.1016/j.jdiacomp.2015.11.019_bb0100) 2011; 33
Muoio (10.1016/j.jdiacomp.2015.11.019_bb0010) 2008; 9
Sarafidis (10.1016/j.jdiacomp.2015.11.019_bb0145) 2007; 21
Taniguchi (10.1016/j.jdiacomp.2015.11.019_bb0005) 2006; 7
Hajian-Tilaki (10.1016/j.jdiacomp.2015.11.019_bb0050) 2015; 6
Ford (10.1016/j.jdiacomp.2015.11.019_bb0045) 2002; 287
Delavari (10.1016/j.jdiacomp.2015.11.019_bb0095) 2009; 32
Hrebicek (10.1016/j.jdiacomp.2015.11.019_bb0080) 2002; 87
Sanyal (10.1016/j.jdiacomp.2015.11.019_bb0025) 2001; 120
Jornayvaz (10.1016/j.jdiacomp.2015.11.019_bb0120) 2012; 15
Motamed (10.1016/j.jdiacomp.2015.11.019_bb0090) 2015
Meigs (10.1016/j.jdiacomp.2015.11.019_bb0015) 2000; 283
Cohen (10.1016/j.jdiacomp.2015.11.019_bb0055) 2011; 332
Eckel (10.1016/j.jdiacomp.2015.11.019_bb0040) 2005; 365
Lomonaco (10.1016/j.jdiacomp.2015.11.019_bb0130) 2012; 55
Fabbrini (10.1016/j.jdiacomp.2015.11.019_bb0060) 2010; 51
Singh (10.1016/j.jdiacomp.2015.11.019_bb0075) 2010; 1
Salgado (10.1016/j.jdiacomp.2015.11.019_bb0115) 2010; 47
Zamani (10.1016/j.jdiacomp.2015.11.019_bb0085) 2014; 17
Duncan (10.1016/j.jdiacomp.2015.11.019_bb0070) 1995; 346
Gayoso-Diz (10.1016/j.jdiacomp.2015.11.019_bb0105) 2013; 13
Chen (10.1016/j.jdiacomp.2015.11.019_bb0140) 2005; 54
Singh (10.1016/j.jdiacomp.2015.11.019_bb0110) 2013; 5
References_xml – volume: 332
  start-page: 1519
  year: 2011
  end-page: 1523
  ident: bb0055
  article-title: Human fatty liver disease: Old questions and new insights
  publication-title: Science
– volume: 54
  start-page: 1914
  year: 2005
  end-page: 1925
  ident: bb0140
  article-title: Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model
  publication-title: Diabetes
– volume: 33
  start-page: 525
  year: 2011
  end-page: 540
  ident: bb0100
  article-title: Systematic review: The diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
  publication-title: Alimentary Pharmacology & Therapeutics
– volume: 346
  start-page: 120
  year: 1995
  end-page: 121
  ident: bb0070
  article-title: A simple measure of insulin resistance
  publication-title: Lancet
– volume: 13
  start-page: 47
  year: 2013
  ident: bb0105
  article-title: Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: Effect of gender and age: EPIRCE cross-sectional study
  publication-title: BMC Endocrine Disorders
– volume: 120
  start-page: 1183
  year: 2001
  end-page: 1192
  ident: bb0025
  article-title: Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
  publication-title: Gastroenterology
– volume: 32
  start-page: 1092
  year: 2009
  end-page: 1097
  ident: bb0095
  article-title: First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran
  publication-title: Diabetes Care
– volume: 37
  start-page: 1595
  year: 1988
  end-page: 1607
  ident: bb0035
  article-title: Banting lecture 1988. Role of insulin resistance in human disease
  publication-title: Diabetes
– volume: 15
  start-page: 574
  year: 2012
  end-page: 584
  ident: bb0120
  article-title: Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance
  publication-title: Cell Metabolism
– volume: 21
  start-page: 709
  year: 2007
  end-page: 716
  ident: bb0145
  article-title: Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type 2 diabetes
  publication-title: Journal of Human Hypertension
– volume: 6
  start-page: 51
  year: 2015
  end-page: 61
  ident: bb0050
  article-title: Metabolic syndrome and its associated risk factors in Iranian adults: A systematic review
  publication-title: Caspian journal of internal medicine
– volume: 9
  start-page: 193
  year: 2008
  end-page: 205
  ident: bb0010
  article-title: Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes
  publication-title: Nature Reviews Molecular Cell Biology
– volume: 5
  start-page: 245
  year: 2013
  end-page: 251
  ident: bb0110
  article-title: A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents
  publication-title: Journal of Clinical Research in Pediatric Endocrinology
– volume: 7
  start-page: 85
  year: 2006
  end-page: 96
  ident: bb0005
  article-title: Critical nodes in signalling pathways: Insights into insulin action
  publication-title: Nature Reviews Molecular Cell Biology
– volume: 142
  start-page: 711
  year: 2012
  end-page: 725
  ident: bb0125
  article-title: Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications
  publication-title: Gastroenterology
– volume: 329
  start-page: 1988
  year: 1993
  end-page: 1992
  ident: bb0020
  article-title: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus
  publication-title: Prospective studies of Pima Indians, The New England Journal of Medicine
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  ident: bb0065
  article-title: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
– volume: 5
  start-page: 1544
  year: 2013
  end-page: 1560
  ident: bb0135
  article-title: Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
  publication-title: Nutrients
– volume: 365
  start-page: 1415
  year: 2005
  end-page: 1428
  ident: bb0040
  article-title: The metabolic syndrome
  publication-title: Lancet
– volume: 18
  start-page: 683
  year: 2001
  end-page: 687
  ident: bb0030
  article-title: Insulin and cancer (review)
  publication-title: International Journal of Oncology
– volume: 55
  start-page: 1389
  year: 2012
  end-page: 1397
  ident: bb0130
  article-title: Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 17
  start-page: 750
  year: 2014
  end-page: 754
  ident: bb0085
  article-title: Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: A population based study
  publication-title: Archives of Iranian Medicine
– volume: 47
  start-page: 165
  year: 2010
  end-page: 169
  ident: bb0115
  article-title: Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals
  publication-title: Arquivos de Gastroenterologia
– volume: 51
  start-page: 679
  year: 2010
  end-page: 689
  ident: bb0060
  article-title: Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
  publication-title: Hepatology
– year: 2015
  ident: bb0090
  article-title: Lipid accumulation product and metabolic syndrome: A population-based study in northern Iran, Amol
  publication-title: Journal of Endocrinological Investigation
– volume: 287
  start-page: 356
  year: 2002
  end-page: 359
  ident: bb0045
  article-title: Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey
  publication-title: JAMA: the journal of the American Medical Association
– volume: 1
  start-page: 36
  year: 2010
  end-page: 47
  ident: bb0075
  article-title: Surrogate markers of insulin resistance: A review
  publication-title: World journal of diabetes
– volume: 283
  start-page: 221
  year: 2000
  end-page: 228
  ident: bb0015
  article-title: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study
  publication-title: JAMA: the journal of the American Medical Association
– volume: 87
  start-page: 144
  year: 2002
  end-page: 147
  ident: bb0080
  article-title: Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention
  publication-title: The Journal of Clinical Endocrinology and Metabolism
– volume: 55
  start-page: 1389
  issue: 5
  year: 2012
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0130
  article-title: Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.25539
– volume: 17
  start-page: 750
  issue: 11
  year: 2014
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0085
  article-title: Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: A population based study
  publication-title: Archives of Iranian Medicine
– volume: 5
  start-page: 1544
  issue: 5
  year: 2013
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0135
  article-title: Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
  publication-title: Nutrients
  doi: 10.3390/nu5051544
– volume: 332
  start-page: 1519
  issue: 6037
  year: 2011
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0055
  article-title: Human fatty liver disease: Old questions and new insights
  publication-title: Science
  doi: 10.1126/science.1204265
– volume: 13
  start-page: 47
  year: 2013
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0105
  article-title: Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: Effect of gender and age: EPIRCE cross-sectional study
  publication-title: BMC Endocrine Disorders
  doi: 10.1186/1472-6823-13-47
– volume: 5
  start-page: 245
  issue: 4
  year: 2013
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0110
  article-title: A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents
  publication-title: Journal of Clinical Research in Pediatric Endocrinology
  doi: 10.4274/Jcrpe.1127
– volume: 7
  start-page: 85
  issue: 2
  year: 2006
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0005
  article-title: Critical nodes in signalling pathways: Insights into insulin action
  publication-title: Nature Reviews Molecular Cell Biology
  doi: 10.1038/nrm1837
– volume: 142
  start-page: 711
  issue: 4
  year: 2012
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0125
  article-title: Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2012.02.003
– volume: 120
  start-page: 1183
  issue: 5
  year: 2001
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0025
  article-title: Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
  publication-title: Gastroenterology
  doi: 10.1053/gast.2001.23256
– volume: 18
  start-page: 683
  issue: 4
  year: 2001
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0030
  article-title: Insulin and cancer (review)
  publication-title: International Journal of Oncology
– volume: 287
  start-page: 356
  issue: 3
  year: 2002
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0045
  article-title: Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey
  publication-title: JAMA: the journal of the American Medical Association
  doi: 10.1001/jama.287.3.356
– volume: 47
  start-page: 165
  issue: 2
  year: 2010
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0115
  article-title: Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals
  publication-title: Arquivos de Gastroenterologia
  doi: 10.1590/S0004-28032010000200009
– volume: 32
  start-page: 1092
  issue: 6
  year: 2009
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0095
  article-title: First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1800
– volume: 87
  start-page: 144
  issue: 1
  year: 2002
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0080
  article-title: Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention
  publication-title: The Journal of Clinical Endocrinology and Metabolism
  doi: 10.1210/jcem.87.1.8292
– volume: 21
  start-page: 709
  issue: 9
  year: 2007
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0145
  article-title: Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type 2 diabetes
  publication-title: Journal of Human Hypertension
  doi: 10.1038/sj.jhh.1002201
– volume: 365
  start-page: 1415
  issue: 9468
  year: 2005
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0040
  article-title: The metabolic syndrome
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)66378-7
– volume: 15
  start-page: 574
  issue: 5
  year: 2012
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0120
  article-title: Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance
  publication-title: Cell Metabolism
  doi: 10.1016/j.cmet.2012.03.005
– volume: 9
  start-page: 193
  issue: 3
  year: 2008
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0010
  article-title: Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes
  publication-title: Nature Reviews Molecular Cell Biology
  doi: 10.1038/nrm2327
– volume: 54
  start-page: 1914
  issue: 7
  year: 2005
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0140
  article-title: Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.7.1914
– volume: 6
  start-page: 51
  issue: 2
  year: 2015
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0050
  article-title: Metabolic syndrome and its associated risk factors in Iranian adults: A systematic review
  publication-title: Caspian journal of internal medicine
– volume: 33
  start-page: 525
  issue: 5
  year: 2011
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0100
  article-title: Systematic review: The diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
  publication-title: Alimentary Pharmacology & Therapeutics
  doi: 10.1111/j.1365-2036.2010.04556.x
– volume: 346
  start-page: 120
  issue: 8967
  year: 1995
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0070
  article-title: A simple measure of insulin resistance
  publication-title: Lancet
  doi: 10.1016/S0140-6736(95)92143-5
– volume: 329
  start-page: 1988
  issue: 27
  year: 1993
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0020
  article-title: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus
  publication-title: Prospective studies of Pima Indians, The New England Journal of Medicine
  doi: 10.1056/NEJM199312303292703
– volume: 28
  start-page: 412
  issue: 7
  year: 1985
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0065
  article-title: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 1
  start-page: 36
  issue: 2
  year: 2010
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0075
  article-title: Surrogate markers of insulin resistance: A review
  publication-title: World journal of diabetes
  doi: 10.4239/wjd.v1.i2.36
– volume: 283
  start-page: 221
  issue: 2
  year: 2000
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0015
  article-title: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study
  publication-title: JAMA: the journal of the American Medical Association
  doi: 10.1001/jama.283.2.221
– volume: 51
  start-page: 679
  issue: 2
  year: 2010
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0060
  article-title: Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
  publication-title: Hepatology
  doi: 10.1002/hep.23280
– volume: 37
  start-page: 1595
  issue: 12
  year: 1988
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0035
  article-title: Banting lecture 1988. Role of insulin resistance in human disease
  publication-title: Diabetes
  doi: 10.2337/diab.37.12.1595
– year: 2015
  ident: 10.1016/j.jdiacomp.2015.11.019_bb0090
  article-title: Lipid accumulation product and metabolic syndrome: A population-based study in northern Iran, Amol
  publication-title: Journal of Endocrinological Investigation
SSID ssj0006551
Score 2.3446655
Snippet The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check...
Abstract Aims The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin...
Aims The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 269
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Child
Cohort Studies
Diagnostic index
Diagnostic Techniques, Endocrine - standards
Endocrinology & Metabolism
Female
Homeostatic model assessment index
Humans
Insulin
Insulin Resistance
Liver
Male
Metabolic syndrome
Metabolic Syndrome - diagnosis
Metabolic Syndrome - metabolism
Middle Aged
Non-alcoholic fatty liver disease
Non-alcoholic Fatty Liver Disease - diagnosis
Non-alcoholic Fatty Liver Disease - metabolism
Quantitative insulin sensitivity check index
Reference Values
ROC Curve
Sensitivity and Specificity
Studies
Young Adult
SummonAdditionalLinks – databaseName: Elsevier ScienceDirect
  dbid: .~1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Li9swEBbLHpZeSrfPbLdFhV6VOIpk2XsLYZekJV36COxNSLYEDlk71M5hL_0T_cM7Y8vZlj5pLwZbIyQ045lPaPQNIa8jl1vHU8fExMfw4JZZE3nmRYrs6hA12luuy3fxfCXeXMmrAzLr78JgWmXw_Z1Pb711-DIKqznaFsXoI9aMTyD8AqQBXKLQDyP7F9j08Mtdmkcs2xKMKMxQ-ptbwuvhGnSAqduY4iWHyOaJjDs_D1C_AqBtILp4QO4HBEmn3SSPyYErH5KjZTgjf0S-XoIXuAaJbNdU3tNtVZRNTQGc0vnlcsoWH6gpc_p-tZi9XdCipAABad5l3BU1rTy9dg2YxqbIaM9n0PYoq5KZrqIuNHnTNDd0g2kdNJzynNEpjNYXBKMYIHPa8tc-JquL80-zOQulF1gG-5uGja3nMokSK9JJnBmTG8EtIJeJgl1nApjEZl4kUhgEWBG3yiunrBxnYwAYFvT7hBzCrNwzQhMvDAfXAFsRI5RPLCBE7uREpIDrAc0MiOzXW2eBlxzLY2x0n4C21r2eNOoJNi0a9DQgo32_bcfM8cceqlen7u-dgqfUEDz-raerww9f67GuuY70D0Y5IOm-53d2_VejnvY2p-8GUjGehAsFza_2zeAT8KDHlK7atTJI4qSk-I1MgtSRSMA4IE87e94vI48BsYDiT_5j8s_JPXiLu3S9U3LYfN65F4DfGvuy_UFvAaptQU4
  priority: 102
  providerName: Elsevier
Title Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1056872715004572
https://www.clinicalkey.es/playcontent/1-s2.0-S1056872715004572
https://dx.doi.org/10.1016/j.jdiacomp.2015.11.019
https://www.ncbi.nlm.nih.gov/pubmed/26718936
https://www.proquest.com/docview/1766592479
https://www.proquest.com/docview/1767078754
https://www.proquest.com/docview/1827920454
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1873-460X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006551
  issn: 1056-8727
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1873-460X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006551
  issn: 1056-8727
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1873-460X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006551
  issn: 1056-8727
  databaseCode: ACRLP
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1873-460X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006551
  issn: 1056-8727
  databaseCode: AIKHN
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1873-460X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006551
  issn: 1056-8727
  databaseCode: AKRWK
  dateStart: 19920101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1873-460X
  dateEnd: 20250801
  omitProxy: true
  ssIdentifier: ssj0006551
  issn: 1056-8727
  databaseCode: 7X7
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1873-460X
  dateEnd: 20250801
  omitProxy: true
  ssIdentifier: ssj0006551
  issn: 1056-8727
  databaseCode: BENPR
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLbYJiEuiPEzsFVG4poucZ044YLKtKllageDSr1ZdmJLrbqkkPTAhX-Cf5j3Eidw2Abikhxiy5bf83vfi5-_R8ibwOTasNT4fGRjeDDtaxVY3_IU2dXBazS3XGfzeLLgH5bR0v1wq1xaZWcTG0Odlxn-Iz9BIsMIggWRvtt-9bFqFJ6uuhIae-QgBKiCWi2WfcAF3rUpv4jF5WHXM_HHDeH1cA3rj2nbmN4VDZHJE9l2bnZOt4HPxgmdPyIPHXqk41bch-SeKR6T-zN3Pv6E_LwEC3ANLbJdXVpLt-WqqCsKwJROLmdjf3pFVZHTT4vp6cWUrgoK8I_mbbbdqqKlpdemBrXYrDLacRk0PYqy8FVbTRc-WVXX3-kGUzqoO-F5S8cwWlcMjKJzzGnDXfuULM7PvpxOfFd2wc8gtqn9UFsWJUGieTqKM6VyxZkG1DISEHEmgEd0ZnkScYXgKmBaWGGEjsIMRBBokO0zsg-zMi8ITSxXDMwChCGKC5toQIfMRCOeAqYHJOORqFtvmTlOciyNsZFd8tladnKSKCcIWCTIySMnfb9ty8rx1x6iE6fs7pyClZTgOP6vp6ncZq9kKCsmA_kZ9QzVDDA2AGXBPJL2PR2eaXHKP4161Omc_D1Qvwc88rr_DPYAD3lUYcpd0wYJnETE72iTIG0kki965Hmrz_0yshjQCgj-5d0TeEUewGzjNhvviOzX33bmGOBZrQdkb_gjHDQ7cUAOxtOLyRze78_mH69-ASteOxM
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkIAXxH8CA4wEj9lSx4kTJISqwdTSdROwSn3z7MSWWnVJIanQPgffg8_IXRIHHmAgpL3kJb7Yyl3ufheff0fIi8Dk2rDU-Dy0MVyY9rUKrG95iuzqEDWaU67To3g04-_n0XyLfHdnYbCs0vnExlHnZYb_yPeQyDCCZEGkb9affewahburroVGaxYTc_4VUrbq9fgt6PclYwfvTvZHftdVwM8Autf-QFsWJUGieRrGmVK54kxDUA4FJFQJhFudWZ5EXCF2CJgWVhiho0E2gNipYenw3CvkKg8Djlz9Yt4neBDNm3aP2MwevAwTv5xIXu4uQd9YJo7lZNEuMociu8_vg-GfwG4T9A5ukZsdWqXD1rxuky1T3CHXpt1-_F3y7Rg8zhmMyDZ1aS1dl4uirigAYTo6ng798Ueqipx-mI33J2O6KCjATZq31X2LipaWnpkazHC1yKjjTmgkirLwVdu9F25ZVdfndIUlJLTbUXpFhzCbaz5GMRjntOHKvUdml6KQ-2QbVmUeEppYrhi4IUh7FBc20YBGmYlCnkIOAcjJI5F73zLrONCxFcdKumK3pXR6kqgnSJAk6Mkje73cumUB-auEcOqU7owreGUJger_JE3VOZdKDmTFZCA_oZ2hmQGmB2AumEfSXrLDTy0u-qdZd5zNyZ8T9d-cR573t8H_4KaSKky5acYgYZSI-AVjEqSpRLJHjzxo7bl_jSwGdASKf3TxAp6R66OT6aE8HB9NHpMbsPK4rQTcIdv1l415AtCw1k-b75GS08t2AD8AFblxvw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkCZeEP8JDDASPGZtHSdOkBCqNqqW0o1_lfrm2YktteqSQlKhfQ6-DZ-OuyQOPMBASHvpS3y1mzvf_a4-_46QZ32TacMS4_PARvDBtK9V3_qWJ8iuDlGjvuU6O47Gc_5mES52yHd3FwbLKp1PrB11VqT4H3kPiQxDSBZE0rNtWcS7o9GrzWcfO0jhSatrp9GYyNScf4X0rXw5OQJdP2ds9PrT4dhvOwz4KcD4yh9oy8K4H2ueBFGqVKY40xCgAwHJVQyhV6eWxyFXiCP6TAsrjNDhIB1AHNXwM-B7r5CrIuABlpOJRZfsQWSvWz9iY3vwOEz8cjt5dbAC3WPJOJaWhQfIIopMP78PjH8CvnUAHN0g11vkSoeNqd0kOya_RfZm7dn8bfLtBLzPGYxIt1VhLd0Uy7wqKYBiOj6ZDf3JB6ryjL6fTw6nE7rMKUBPmjWVfsuSFpaemQpMcr1MqeNRqCXyIvdV08kXHllVVed0jeUktD1dekGHMJtrREYxMGe05s29Q-aXopC7ZBdWZe4TGluuGLgkSIEUFzbWgEyZCQOeQD4BKMojoXvfMm350LEtx1q6wreVdHqSqCdIliToySO9Tm7TMIL8VUI4dUp33xU8tISg9X-SpmwdTSkHsmSyLz-inaGZAb4HkC6YR5JOssVSDUb6p1n3nc3JnxN1-88jT7vH4IvwgEnlptjWY5A8SoT8gjExUlYi8aNH7jX23L1GFgFSAsU_uHgBT8gebH35dnI8fUiuwcKjpihwn-xWX7bmEaDESj-utyMlp5e9_38AsRR1-g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimal+cutoff+points+for+HOMA-IR+and+QUICKI+in+the+diagnosis+of+metabolic+syndrome+and+non-alcoholic+fatty+liver+disease%3A+A+population+based+study&rft.jtitle=Journal+of+diabetes+and+its+complications&rft.au=Motamed%2C+Nima&rft.au=Miresmail%2C+Seyed+Javad+Haji&rft.au=Rabiee%2C+Behnam&rft.au=Keyvani%2C+Hossein&rft.date=2016-03-01&rft.pub=Elsevier+Inc&rft.issn=1056-8727&rft.volume=30&rft.issue=2&rft.spage=269&rft.epage=274&rft_id=info:doi/10.1016%2Fj.jdiacomp.2015.11.019&rft.externalDocID=S1056872715004572
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10568727%2FS1056872716X00025%2Fcov150h.gif